EdgarLookup

Zymeworks Inc. — Insider Transactions

Form 4 filings by directors, officers, and 10%+ shareholders

SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.

Overview All Filings Annual Quarterly Insiders
Insider Title Type Shares Price Value Owns After Date
Galbraith Kenneth Chair & CEO Option Exercise 100,000 180,803 Dec 22, 2025
Ciongoli Gregory Austin Award / Grant 415,000 $12.02 $4,988,300 488,500 Aug 12, 2025
NODELMAN OLEG Tax Withholding 41 $12.71 $521 22,970,388 Jun 26, 2025
EcoR1 Capital, LLC Purchase 49,502 $11.43 $565,808 17,877,989 May 19, 2025
EcoR1 Capital, LLC Purchase 54,760 $11.52 $630,835 17,828,487 Apr 16, 2025
NODELMAN OLEG Purchase 196,438 $11.17 $2,194,212 17,699,774 Apr 3, 2025
EcoR1 Capital, LLC Purchase 4,397 $11.75 $51,665 17,259,548 Apr 1, 2025
EcoR1 Capital, LLC Purchase 53,501 $12.91 $690,698 17,211,303 Mar 26, 2025
EcoR1 Capital, LLC Purchase 22,689 $13.08 $296,772 17,157,802 Mar 20, 2025
EcoR1 Capital, LLC Purchase 56,277 $12.23 $688,268 16,858,418 Mar 19, 2025
NODELMAN OLEG Purchase 320,690 $11.49 $3,684,728 16,040,851 Mar 13, 2025
EcoR1 Capital, LLC Purchase 19,748 $13.87 $273,905 15,720,161 Jan 16, 2025
EcoR1 Capital, LLC Purchase 74,125 $13.39 $992,534 15,485,203 Jan 15, 2025
EcoR1 Capital, LLC Purchase 21,021 $14.07 $295,765 15,206,980 Jan 10, 2025
Moore Paul Andrew Chief Scientific Officer Option Exercise 17,166 24,533 Jan 6, 2025
Galbraith Kenneth Chair & CEO Option Exercise 47,666 71,428 Jan 6, 2025
Smith Jeffrey T L EVP & Chief Medical Officer Sale 11,110 $14.92 $165,761 8,890 Jan 6, 2025
EcoR1 Capital, LLC Purchase 146,501 $14.57 $2,134,520 15,028,079 Dec 30, 2024
EcoR1 Capital, LLC Purchase 11,958 $14.12 $168,847 14,704,239 Dec 27, 2024
EcoR1 Capital, LLC Purchase 298,818 $13.53 $4,043,008 13,736,291 Dec 23, 2024
Moore Paul Andrew Chief Scientific Officer Sale 7,460 $10.65 $79,449 9,706 Jan 8, 2024
Astle Christopher SVP & Chief Financial Officer Sale 4,563 $10.65 $48,596 7,934 Jan 5, 2024
Galbraith Kenneth Chair & CEO Sale 18,198 $10.65 $193,809 29,468 Jan 5, 2024
Astle Christopher SVP & Chief Financial Officer Option Exercise 1,550 2,883 Dec 11, 2023
EcoR1 Capital, LLC Purchase 3,350,000 $8.12 $27,202,000 13,437,473 Jun 16, 2023
EcoR1 Capital, LLC Purchase 200,000 $8.00 $1,600,000 10,087,473 Mar 28, 2023
Klompas Neil A President & COO Sale 2,977 $7.83 $23,310 17,032 Mar 10, 2023
EcoR1 Capital, LLC Purchase 144,100 $9.49 $1,367,509 9,724,073 Jan 20, 2023
EcoR1 Capital, LLC Purchase 203,000 $10.00 $2,030,000 9,579,973 Jan 17, 2023
EcoR1 Capital, LLC Purchase 920,000 $7.65 $7,038,000 8,488,573 Jan 11, 2023
Astle Christopher SVP & Chief Financial Officer Option Exercise 1,550 2,220 Dec 12, 2022
Astle Christopher SVP & Chief Financial Officer Option Exercise 1,550 2,220 Dec 12, 2022
Josephson Neil Chief Medical Officer Sale 2,475 $8.10 $20,048 14,449 Nov 10, 2022
Josephson Neil Chief Medical Officer Sale 2,475 $8.10 $20,048 14,449 Nov 10, 2022
Redmile Group, LLC Award / Grant 30,481 $5.03 $153,319 6,075,918 Oct 13, 2022
Redmile Group, LLC Purchase 30,481 $5.03 $153,319 6,075,918 Oct 13, 2022